Associate Prof. of Bioengineering, University of Pisa, Head of In-Vitro Models Group and NanoBioscopy Lab at the National Council of Research Institute of Clinical Physiology (CNR-IFC). Also involved in capacity building in the field of Biomedical Engineering, in association with UNECA and FABLAB Pisa .Author of over 100 peer-reviewed publications and of several patents on microfabrication and on bioreactors, co-founder of 2 high-tech companies.
Dr Alamian is Associate Dean for Health Studies and Associate Professor at University of Miami (UM) School of Nursing and Health Studies (SONHS). A fellow of the American College of Epidemiology, Dr Alamian oversees the public health and health science programs of the UM SONHS. Dr Alamian’s research interests include cluster-risk and theoretical modeling of risk behaviors and risk factors for chronic disease including metabolic syndrome, diabetes, and cardiovascular disease. He has been investigator on multiple NIH and state grants on pediatric obesity, metabolic syndrome, and biomarkers for chronic liver disease. Dr Alamian received his doctoral degree in public health, with specialization in epidemiology, from the University of Montreal School of Public Health. He completed a fellowship in public health through a Canadian Institutes of Health Research fellowship program at McGill University, and holds a master of science degree in pharmacy, with specialization in pharmacoepidemiology, from Laval University.
Giuseppina obtained her MSc in Cellular and Molecular Biology in 2009 at the University of Rome Tor Vergata, Italy. After spending two years in the laboratory of Prof. Susanna Dolci (Tor Vergata Faculty of Medicine, Rome), she moved to Milan in the laboratory of Prof. Pier Paolo Di Fiore (IFOM-IEO Institute ).
During this time she worked on the generation of a c-Kit transgenic mouse model and regulation of spermatogenesis, 3D cell cultivation and characterization of stem cells from murine breast and prostate tissue and breast biopsy.
She graduated in 2015 at the SBP Graduate School of Biomedical Science; La Jolla, CA, USA. under the supevision of Prof. Ze'ev Ronai. She extended her training in the Ronai's laboratory until December 2016, During this time she worked on prostate cancer and melanoma using cell lines and murine models. She gained experience in transcription regulation, splicing and mouse pathology.
Currently, under the mentorsip of Prof. Caroline Robert and Dr. Stéphan Vagner, she is working at the Gustave Roussy Institute. Her studies are focused on metabolism and translation regulation in melanoma biology.
Senior Lecturer in Biological Sciences at the University of Huddersfield, since 2015. Previously Junior Research Fellow, College Lecturer In Biochemistry and various postdocs at the University of Oxford (2013-15). Working on DNA replication, genome integrity and transcription factors in human cancers (and also in prokaryotes). Additional interests in phylogenomics and novel protein expression systems.
Graduated in Medicine and Surgery at the University of Catania, Italy, specialist in Endocrinology and in Internal Medicine, PhD in Endocrinological and Metabolic Sciences. Full professor of Clinical Pathology, University "Magna Græcia" of Catanzaro, Italy.
Her scientific field of interest is related to endocrinology and metabolism, and to the study of novel biomarkers in human diseases. She is author of more than 120 scientific publications. Dr. Foti is a member of the Italian Society of Pathology and Laboratory Medicine (SIPMeL) and of the Italian Society of Pathology and Translational Medicine (SIPMeT).
Professor of Cardio-metabolic Health in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow. Lead an active multi-disciplinary research group investigating the effects of exercise and diet on the prevention and management of vascular and metabolic diseases from the molecular to the whole-body level. Major research interests include: why certain population groups appear to be particularly susceptible to the adverse effects of a ‘Westernised’ lifestyle, and how lifestyle interventions can modulate this excess risk; the interactions between physical activity, energy balance, body fatness and disease risk; and the mechanisms by which exercise regulates lipoprotein metabolism. Member of the NICE guidelines update committee for prevention of type 2 diabetes, and was member of development groups for the Scottish Intercollegiate Guidelines Network (SIGN) guidelines for the prevention and treatment of obesity and for prevention of cardiovascular disease. Past Chair of the British Association of Sport and Exercise Sciences (BASES) Division of Physical Activity for Health and Fellow of BASES. Director of the MSc programme in Sport and Exercise Science & Medicine at the University of Glasgow.
Dr. Gillespie is an evolutionary biologist with broad interests in organismal and molecular evolution. The major focus of his current research is deciphering the mechanisms by which obligate intracellular species of Rickettsiales (Alphaproteobacteria) invade, survive and replicate within eukaryotic cells.
In research funded by the National Institutes of Health, Dr. Gillespie utilizes phylogenetics, comparative genomics and bioinformatics to guide experimental research on various pathogenic species of Rickettsia and their associated arthropod vectors. His early research resulted in the reclassification of Rickettsia species and the identification of many lineage-specific pathogenicity factors. Through years of intense scrutinization of dozens of diverse rickettsial genomes, Dr. Gillespie and colleagues have described a large, dynamic mobilome for Rickettsia species, resulting in the identification of integrative conjugative elements as the vehicles for seeding Rickettsia genomes with many of the factors underlying obligate intracellular biology and pathogenesis. Via an iterative process of genome sequencing, phylogenomics, bioinformatics, and classical molecular biology and microbiology, Dr. Gillespie continues to lead and assist research projects on the characterization of rickettsial gene and protein function.
Dr. Mahesh Gokara is a Postdoctoral Research Fellow in the Department of Cancer Biology at the Mayo Clinic. He has a Ph.D biochemistry with an experience of over 10 years in multidisciplinary research areas including biochemistry, biophysics and bioinformatics.
Dr. Hoy is Head of the Lipid Metabolism Laboratory in the School of Medical Sciences. His lab is a member of the Charles Perkins Centre. He is a Visiting Scientist in the Cancer Division of the Garvan Institute of Medical Research.
Dr. Hoy completed his BSc (Biomed Sc) and MSc (Research) at the University of Wollongong and PhD studies at the Garvan Institute of Medical Research. He performed postdoctoral training at Monash University where he was a recipient of an NHMRC Biomedical Australian Research Fellow (2010-2013).
Dr. Hoy's laboratory is focused on the regulation of lipid metabolism, predominantly fatty acid storage and utilisation, and how this may be perturbed in chronic disease states such as cancer, obesity and insulin resistance.
Dr. Sushil Kumar is a Research Assistant professor at the Oregon Health & Science University (OHSU), Portland Oregon. He obtained his PhD from Max Planck Institute for biochemistry, Munich Germany where he worked in supervision of Prof. Axel Ullrich for studying cancer cell signaling. He did his postdoctoral work in Prof. Reto Schwendener’s laboratory at University of Zurich where he developed liposomal drugs for targeted delivery of payloads to macrophages as novel cancer therapy approach. He joined OHSU in 2012 in Prof. Lisa Coussens' laboratory where he has continued his research for studying cancer inflammation and developing immunotherapeutic approaches for cancer. He is employing ex vivo as well as mouse models for understanding immune cell phenotype for analyzing their role in cancer progression and developing novel therapeutics as well as biomarkers for cancer.
Prof. Marunaka is the Representative Director, Director of Clinical, and Director of Medical Research Institute, Kyoto Industrial Health Association; Professor, Research Center for Drug Discovery and Pharmaceutical Development, Ritsumeikan University; Jinshan Distinguished Professor, International Research Center for Food Nutrition and Safety, Jiangsu University; Professor Emeritus, Kyoto Prefectural University of Medicine; President, Physiological Society of Japan. MD (1979), PhD (1985), Kyoto Prefectural University of Medicine; National License of Physician and Surgeon, Japan (1979). He was Professor and Chairperson, Departments of Molecular Cell Physiology and Bio-Ionomics, Kyoto Prefectural University of Medicine, Japan, and Director and Professor, Japan Institute for Food Education and Health, St. Agnes’ University. He was awarded “Vebleo Nanomedicine Scientist Award” (Sweden), “Marco Polo della Scienza Italiana” (Italy), The Premier's Research Excellence Award (Canada), Scholar Award (Medical Research Council of Canada) and Research Award from National Kidney Foundation of USA. He has obtained more than 60 research grants, published more than 250 peer reviewed articles, and provided more than 30 invited plenary lectures at international congresses and research conferences. h-index 40, i10-index 161, Citation 5714
Interested in metabolomics and genomics of diseases! My current work is focused on generating quality metabolomics datasets leveraging the high-resolution mass-spectrometry (GC-Orbitrap-MS and LC-Orbitrap-MS) and occasionally NMR datasets to combine with other -omics layers such as genomics (transcriptomics, epigenetics), proteomics, and clinical data sets to provide insights in metabolic changes that are associated with human and non-human primate wellness and disease conditions, specifically metabolic syndromes such as atherosclerosis, diabetes, obesity, and Alzheimer’s disease.